New and emerging type 2 diabetes therapies with novel MOAs that reduce hyperglycemia while preserving insulin secretion, preventing hypoglycemia and controlling body weight. Explore renal glucose reabsorption via selective inhibition of the sodium-glucose transporter-2.
Please go through below link to understand more.
Center for HealthCare Education
http://www.medpagetoday.com/webcast/CHCE01/?mptts=20101005081329
Posts
No comments:
Post a Comment